Ignite Creation Date:
2025-12-25 @ 4:10 AM
Ignite Modification Date:
2026-02-25 @ 4:52 AM
Study NCT ID:
NCT02950220
Status:
COMPLETED
Last Update Posted:
2019-07-30
First Post:
2016-10-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Sponsor:
Kami Maddocks
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-12
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-03
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-28
First Submit QC Date:
None
Study First Post Date:
2016-11-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-29
Last Update Post Date:
2019-07-30
Last Update Post Date Type:
ACTUAL